Prognostic value of flow-mediated dilatation following myocardial infarction

Marco Guazzi1, Giuseppe Reina, Paola Gripari

  • 1University of Milano, San Paolo Hospital, Cardiopulmonary Unit, Cardiology Division, Milano, Italy.

Insights

Flow-mediated dilatation (FMD) can help predict cardiovascular events after myocardial infarction (MI). Patients with diabetes and lower FMD have a significantly higher risk of future cardiovascular events.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Medical Diagnostics

Background:

  • Risk stratification for cardiovascular events post-myocardial infarction (MI) is crucial.
  • Flow-mediated dilatation (FMD) shows promise as a prognostic indicator.
  • This study evaluates FMD's prognostic value in uncomplicated MI patients.

Purpose of the Study:

  • To investigate the prognostic value of flow-mediated dilatation (FMD) in patients following a myocardial infarction (MI).
  • To determine if FMD can improve risk stratification for subsequent cardiovascular events.

Main Methods:

  • 179 post-MI patients (mean age 64.8 years) underwent brachial artery ultrasound to measure FMD.
  • Patients were monitored for subsequent cardiovascular events over a mean period of 13.7 months.
  • Medical chart review was used for data collection and event tracking.

Main Results:

  • 45 cardiovascular events occurred during follow-up.
  • Diabetes diagnosis and FMD (percent arterial diameter change 4.5%) were significant predictors.
  • Kaplan-Meier analysis showed event-free survival rates ranging from 38.5% to 88.7% based on diabetes status and FMD.

Conclusions:

  • Non-invasive FMD is a potential risk factor after MI.
  • FMD may provide additional information for conventional cardiovascular risk stratification.
  • Further studies are needed to validate these findings.
Abstract

Related Concept Videos